(Q44762261)

English

Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Takahisa Yamane

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ryousuke Yamamura

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yasutaka Aoyama

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hirohisa Nakamae

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Taro Hasegawa

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Chikahiko Sakamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hisako Shibata

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yoshiki Terada

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Genju Koh

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Masayuki Hino

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2095-2097

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000123483

21 January 2018

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000123483

21 January 2018

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000123483

21 January 2018

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000123483

21 January 2018

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000123483

21 January 2018

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000123483

21 January 2018

Identifiers

10.1080/1042819031000123483

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

release_shk5adptrfd6xdujcv7dsz54yi

1 reference

https://api.fatcat.wiki/v0/release/shk5adptrfd6xdujcv7dsz54yi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44762261&oldid=2039444174"